Your Location：
Home >
Browse articles >
Combination of Activating Blood Circulation and Detoxifying Chinese Medicines Played an Anti-Inflammatory Role in Unstable Angina Patients after Percutaneous Coronary Intervention: A Multicenter, Open-Labeled, Randomized Controlled Trial
OriginalPaper | Updated：2021-09-24
|

    • Combination of Activating Blood Circulation and Detoxifying Chinese Medicines Played an Anti-Inflammatory Role in Unstable Angina Patients after Percutaneous Coronary Intervention: A Multicenter, Open-Labeled, Randomized Controlled Trial

    • Combination of Activating Blood Circulation and Detoxifying Chinese Medicines Played an Anti-Inflammatory Role in Unstable Angina Patients after Percutaneous Coronary Intervention: A Multicenter, Open-Labeled, Randomized Controlled Trial

    • 中国结合医学杂志（英文版）   页码：1-8

    Scan for full text

  • Xiao-juan Ma, Wen-hui Duan, Ying Zhang, 等. Combination of Activating Blood Circulation and Detoxifying Chinese Medicines Played an Anti-Inflammatory Role in Unstable Angina Patients after Percutaneous Coronary Intervention: A Multicenter, Open-Labeled, Randomized Controlled Trial[J/OL]. 1-8. DOI：

    Xiao-juan Ma, Wen-hui Duan, Ying Zhang, et al. Combination of Activating Blood Circulation and Detoxifying Chinese Medicines Played an Anti-Inflammatory Role in Unstable Angina Patients after Percutaneous Coronary Intervention: A Multicenter, Open-Labeled, Randomized Controlled Trial[J/OL]. 1-8. DOI：

  •  
  •  
FULL TEXT LINK
More>

0

浏览量

0

Downloads

0

CSCD

文章被引用时，请邮件提醒。
Submit
工具集
参考文献导出
分享
收藏
添加至我的专辑

相关文章

Efficacy of Biejiajian Pill on Intestinal Microbiota in Patients with Hepatitis B Cirrhosis/Liver Fibrosis: A Randomized Double-Blind Controlled Trial
Schisandrin B Protects against Ischemic Brain Damage by Regulating PI3K/AKT Signaling in Rats
Reyanning Mixture on Asymptomatic or Mild SARS-CoV-2 Infection in Children and Adolescents: A Randomized Controlled Trial
Polypeptide from Moschus Suppresses Lipopolysaccharide-Induced Inflammation by Inhibiting NF-κ B-ROS/NLRP3 Pathway

相关作者

暂无数据

相关机构

Center of Liver Diseases Division 3, Beijing Ditan Hospital, Capital Medical University, Beijing, China;Beijing Key Laboratory of Emerging Infectious Diseases, Institute of Infectious Disease, Beijing Ditan Hospital, Capital Medical University, Beijing, China;National Center for Infectious Diseases, Beijing, China;Peking University Ditan Teaching Hospital, Beijing, China;Central of Integrated Chinese and Western Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing, China;China Traditional Chinese Medicine Holdings Co. Limited, Guangzhou, China
Department of Neurology, The First Hospital of Quanzhou Affiliated to Fujian Medical University, Quanzhou, Fujian Province, China;Department of Neurosurgery, Fujian Medical University Union Hospital, Fuzhou, China
Department of Emergency, Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China;Acupuncture and Massage College, Shanghai University of Traditional Chinese Medicine, Shanghai, China;Department of Health Management, The First Affiliated Hospital of Nanchang University, Nanchang, China;Jiangxi Provincial Traditional Chinese Medicine Nephropathy Clinical Research Center, Jiujiang Hospital of Traditional Chinese Medicine, Jiujiang, Jiangxi Province, China;Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Nanchang University, Nanchang, China;Institute of Critical Care, Shanghai University of Traditional Chinese Medicine, Shanghai, China
Department of Pharmacology, Southwest Medical University, Luzhou, Sichuan Province, China;Sichuan Institute for Translational Chinese Medicine, Translational Chinese Medicine Key Laboratory of Sichuan Province, Sichuan Academy of Chinese Medicine Sciences, Chengdu, China;Hunan Provincial Key Laboratory of the Research and Development of Novel Pharmaceutical Preparations, College of Pharmacy, Changsha Medical University, Changsha, China;Sichuan Fengchun Pharmaceutical Co., Ltd., Deyang, Sichuan Province, China;Sichuan Ant Recommendation Biotechnology Co., Ltd., Chengdu, China
0